Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    ALZHEIMER DISEASE 14
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects
Condition: Alzheimer Disease
Intervention: Drug: SAM-531
2 Recruiting Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Condition: Alzheimer's Disease Prevention
Intervention: Behavioral: Aerobic vs. Non-Aerobic exercise
3 Completed Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly
Condition: Alzheimer's Disease
Intervention: Other: Ketasyn
4 Terminated Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: AZD3480
5 Completed A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
Conditions: Healthy Volunteers;   Mass Balance Study
Intervention: Drug: AZD3293
6 Recruiting Effects of Brain Beta-Amyloid on Postoperative Cognition
Condition: Postoperative Cognitive Dysfunction
Interventions: Drug: Florbetapir F 18 (18F-AV-45);   Other: no intervention

Indicates status has not been verified in more than two years